Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE0010 dose-response in metformin-treated type 2 diabetes
NCT00299871Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2006
- Primary completion
- Aug 2007
- Modality
- Peptides
- Countries
- 7
01
Overview
A Phase 2 trial of lixisenatide in type 2 diabetes mellitus (T2DM), sponsored by Sanofi. Started Feb 2006; status: completed.
02
Drugs
lixisenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00299871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00299871.